Legend Biotech Corp (LEGN) Net Cash Flow (2019 - 2025)

Legend Biotech (LEGN) has reported Net Cash Flow for 7 consecutive years, with $625.7 million the latest figure, recorded in Q4 2025.

• Net Cash Flow for Q4 2025 came in at $625.7 million, up 467.41% year-over-year; the trailing twelve-month figure through Dec 2025 was $609.2 million (up 161.6% YoY), and the FY2025 annual result was $609.1 million, up 161.59% from the prior year.
• Net Cash Flow was $625.7 million for Q4 2025 at Legend Biotech, up from $9.5 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $625.7 million in Q4 2025 and troughed at -$696.3 million in Q2 2024.
• Average Net Cash Flow over 5 years is $1.2 million, with a median of -$34.7 million recorded in 2021.
• Year-over-year, Net Cash Flow plunged 611.55% in 2022 and jumped 19899.89% in 2023.
• Over 5 years, Net Cash Flow stood at -$69.9 million in 2021, then surged by 63.38% to -$25.6 million in 2022, then jumped by 1322.17% to $312.8 million in 2023, then plunged by 154.45% to -$170.3 million in 2024, then jumped by 467.41% to $625.7 million in 2025.
• Per Business Quant data, the three most recent Net Cash Flow figures were $625.7 million in Q4 2025, $9.5 million in Q3 2025, and -$179.6 million in Q2 2025.